Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes

Journal of Molecular Medicine

Volumn 80, Issue 2, 2002, Pages 96-104

  Morris, Brian J ^a   Markus, Andrea M ^a   Glenn, Cheryl L ^a   Adams, David J ^a   Colagiuri, S ^b   Wang, Xing ^c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DNA BINDING; DNA DETERMINATION; DNA FLANKING REGION; DNA SEQUENCE; EUROPE; FEMALE; GENE ACTIVITY; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; KIDNEY CELL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PROMOTER REGION; REPORTER GENE;

EID: 0036182269     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-001-0287-1     Document Type: Article

References (53)

1. Diabetic retinopathy in identical twins
2. Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial
3. Diabetes; from phenotypes to genotypes
4. Genetic markers of increased susceptibility to diabetic nephropathy
5. Genetic determinants of diabetic nephropathy
6. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
7. Evolution of incipient nephropathy in type 2 diabetes
8. Nitric oxide in diabetic nephropathy
9. Nitric oxide synthases catalyze superoxide formation
10. Nitric oxide as a bifunctional regulator of apoptosis
11. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
12. Vascular dysfunction in diabetes mellitus
13. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats
14. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products
15. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis
16. Glomerular actions of nitric oxide
17. Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy
18. Evidence for iNOS-dependent peroxynitrite production in diabetes platelets
19. High glucose enhances growth factor-stimulated nitric oxide production by cultured rat mesangial cells
20. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats
21. The chemical biology of nitric oxide: Insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide
22. Endothelial nitric oxide synthase gene sequence variations and vascular disease
23. Inducible nitric oxide synthase in human diseases
24. A bi-allelic tetranucleotide repeat in the promoter of the human inducible nitric oxide synthase gene
25. Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene
26. Sequence diversity in 36 candidate genes for cardiovascular disorders
27. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis
28. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
29. Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives
30. Viral promoter expression in CEM-C7 and Jurkat human T-lymphoid cell lines
31. Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells
32. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites
33. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene
34. Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes
35. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter
36. Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic nephropathy
37. Site-specific insertion and deletion mutants in the mer promoter-operator region of Tn501; the nineteen base-pair spacer is essential for normal induction of the promoter by MerR
38. Spacing of promoter elements regulates the basal expression of the soxS gene and converts SoxR from a transcriptional activator into a repressor
39. Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1
40. Identification of functional elements in the bidirectional promoter of the mouse Nthl1 and Tsc2 genes
41. Location of an inducible nitric oxide synthase mRNA in the normal kidney
42. Increased nitric oxide synthase mRNA expression in the renal medulla of water-deprived rats
43. Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase
44. Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats
45. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis
46. Endothelial cell dysfunction leading to diabetic nephropathy
47. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats
48. Beneficial and harmful effects of L-arginine on renal ischaemia
49. Nitric oxide donors induce stress signalling via ceraminde formation in rat mesangial cells
50. Enhanced expression of vsmNOS mRNA in glomeruli from rats with unilateral ureteral obstruction
51. Role of angiotensin II in diabetic nephropathy
52. CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients